Let’s talk about serialization!

Two years ago was the first day after the "point of no return" for prescription Rx and Gx medicines. The Falsified Medicines Directive (FMD) had been fully rolled out and serialisation had become mandatory. For most CPOs, CMOs and packaging departments of MAHs, the time prior to launch was relentless. Company systems, structures and culture had to integrate parallel computing as a new integral part of the physical packaging process. Early industry reports said there would be almost no long-term burden. Yes, that is true for big brands. But small brands and batch sizes struggle with the daily routine of additional serialisation sub-processes with aggregation as the icing on the cake. The lucky ones got an early start, like we did in 2014. When did your experience and learning curve start? Let's talk about it!